Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FJ2KZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,088
Award facts
- Contract value 100% obligated
- $57,088.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $57,088.48 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml format, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order, awarded competitively without set-aside provisions, represents a pharmaceutical supply transaction under the company's broader federal medical supply contract portfolio. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain and military healthcare systems.
This delivery order operates as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 billion and extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's contract portfolio demonstrates extensive federal experience fulfilling medical procurement requirements across multiple therapeutic domains, including specialty medications and branded pharmaceuticals, positioning it as a significant vendor within the Defense Health Agency's medical supply ecosystem.
Quick answers
Who was awarded contract SPE2DB25FJ2KZ?
SPE2DB25FJ2KZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FJ2KZ worth?
The government has obligated $57,088 on SPE2DB25FJ2KZ.
Is contract SPE2DB25FJ2KZ an order under another contract?
Yes. SPE2DB25FJ2KZ is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ2KZ competed?
The extent of competition for SPE2DB25FJ2KZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award